This is a mid-term election year, meaning that some familiar issues investors should be aware of are popping up yet again. That includes reducing pharmaceutical prices. Market participants may view the reappearance of the drug price debate as ill-timed on the basis that the healthcare sector is struggling this year, but some analysts believe that [...] The post Pharma Stocks, ETFs Can Deal With Drug Pricing Legislation appeared first on ETF Trends .